Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review
Cancers · 05.08.2026 · 18 (15) · 2510
DOI: 10.3390/cancers18152510 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 05.08.2026. Verfasst von Wenqiao Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, West China Hospital of Sichuan University, 37Guoxue Lane, Chengdu 610041, China. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Olfactory neuroblastoma (ONB), also known as esthesioneuroblastoma, is a rare malignant tumor arising from the olfactory epithelium of the sinonasal tract. Surgery combined with radiotherapy remains the standard treatment for localized disease, whereas chemotherapy is mainly used in advanced or recurrent cases. However, recurrent and metastatic ONB continues to present major therapeutic challenges, and traditional staging and histological grading systems cannot fully explain the marked differences in clinical behavior among patients. The primary objective of this review is to summarize recent advances in the molecular pathology, tumor microenvironment (TME), and emerging targeted therapeutic strategies in ONB. Emerging genomic and transcriptomic studies suggest that ONB comprises biologically heterogeneous tumors with distinct molecular and transcriptional programs associated with proliferation, neuroendocrine differentiation, angiogenesis, and stromal remodeling. Furthermore, we explore the increasing attention directed toward the TME, including immune-cell infiltration, angiogenic signaling, and immune checkpoint expression, which may influence therapeutic response. These molecular findings have generated interest in several potential targeted treatment strategies, including peptide receptor radionuclide therapy (PRRT), anti-angiogenic therapy, epigenetic-targeted therapy, immunotherapy, and DNA-damage-response-targeted approaches. Ultimately, although the current evidence remains limited because of the rarity of the disease, novel therapeutic strategies for ONB are emerging. In addition to summarizing the current landscape, this review discusses the translational challenges and future directions for precision oncology and biomarker-driven therapy, aiming to provide insights for improving individualized patient management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, West China Hospital of Sichuan University, 37Guoxue Lane, Chengdu 610041, China.
ORCID-Profile: Wenqiao Zhou, Xingchen Liu
Zitieren
APA
Zhou, W., Liu, X., Hu, J., Chen, Y., Liu, F., & Zhong, B. (2026). Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review. Cancers, 18(15), 2510. https://doi.org/10.3390/cancers18152510
Vancouver
Zhou W, Liu X, Hu J, Chen Y, Liu F, Zhong B. Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review. Cancers. 2026;18(15):2510. doi:10.3390/cancers18152510
BibTeX
@article{Zhou2026,
author = {Zhou, Wenqiao and Liu, Xingchen and Hu, Junying and Chen, Yu and Liu, Feng and Zhong, Bing},
title = {Pathological Pathways of Olfactory Neuroblastoma: From Molecular Mechanisms to Targeted Therapy: A Narrative Review},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2510},
doi = {10.3390/cancers18152510}
}
EUVIMED